Feasibility of a novel, synthetic, self-assembling peptide for suture-line haemostasis in cardiac surgery

Backgroud To assess the feasibility and efficacy of PuraStat®, a novel haemostatic agent, in achieving suture line haemostasis in a wide range of cardiac surgical procedures and surgery of the thoracic aorta.